For the pharmaceutical industry, it varies on every company
on how they structure themselves, but most of the time they structure
themselves on their products. In general, the structure of a product defines
the tasks that must be completed to deliver a product to end-users. An
industry’s structure emerges from the various ways firms organize themselves to
complete those tasks. Some firms structure themselves to have the product
production go straight from start to finish, while others divide the tasks and
collaborate on how to produce the product to the consumers. Companies do end up
having similar questions on the decision on what their products should be,
generic or brand. If gone in either way, the division of tasks is modified to
fit that product. Sometimes there is an interpersonal faction to the companies
that cater the product to the consumer’s need, like costumer service, only
indirectly. But the majority of any company’s workforce may be their R&D
(research and development) department. The R&D department basically creates
and product and determines it usage, while the rest of the work force, decide
where it goes. Because of more competition in recent years resulting from a lot
of drugs coming off patent, companies have expanded their R&D departments
to develop similar or enhanced versions of already popular drugs. R&D is
vastly the most important part of any pharmaceutical company at this point of
the industry.
Anderson, Scott John. "Georgetown University." Georgetown
University. (2003): n. page. Web. 19 Nov. 2012.
<http://cct.georgetown.edu/research/thesisdatabase/ScottAnderson.pdf>.
Marron,
Donald. "CBO." CBO. (2006): n. page. Web. 19 Nov. 2012. <http://www.cbo.gov/sites/default/files/cbofiles/ftpdocs/76xx/doc7615/10-02-drugr-d.pdf>.
No comments:
Post a Comment